Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Neurology|September 13, 2006
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCVC Briani, L Chemello, G Zara, et al.Clinical and Experimental Rheumatology|October 28, 2006
Increased titres of IgM anti-heparan sulfate antibody in Behçet's diseaseC Briani, A Doria, R Marcolongo, et al.Cancer|January 28, 1998
Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II studyA A Brandes, A Rigon, P Zampieri, et al.Journal of Neurology|May 20, 1998
Radiological evidence of subclinical dysphagia in motor neuron diseaseC Briani, M Marcon, M Ermani, et al.Neurology|February 16, 2006
Is protracted low-dose temozolomide feasible in glioma patients?A Tosoni, G Cavallo, M Ermani, et al.British Journal of Cancer|October 7, 2006
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)A A Brandes, A Tosoni, G Cavallo, et al.Rheumatology (Oxford, England)|September 9, 2004
Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of ageS Rinaldi, A Doria, F Salaffi, et al.Journal of Hepatology|November 4, 2000
The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantationM De Bona, P Ponton, M Ermani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II studyA A Brandes, M Ermani, U Basso, et al.Rheumatology (Oxford, England)|September 16, 2004
Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinantsA Doria, S Rinaldi, M Ermani, et al.Pageof 9